GENinCode Plc (LON:GENI – Get Free Report)’s stock price was down 7.7% on Friday . The company traded as low as GBX 0.85 and last traded at GBX 0.88. 4,606,875 shares traded hands during mid-day trading, a decline of 12% from the average daily volume of 5,226,285 shares. The stock had previously closed at GBX 0.95.
GENinCode Price Performance
The stock has a 50 day moving average of GBX 0.87 and a two-hundred day moving average of GBX 1.01. The company has a debt-to-equity ratio of 117.74, a quick ratio of 15.88 and a current ratio of 0.93. The stock has a market cap of £6.60 million, a PE ratio of -0.42 and a beta of 0.59.
GENinCode Company Profile
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
Read More
- Five stocks we like better than GENinCode
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
